Vitamins, minerals and nutraceuticals selected through scientific review.
Science-led immune health
T-Boostersupportsimmune healthby enhancingthymus function
A science-led nutritional formulation developed by drug-discovery researchers and evaluated through a randomised human study.
Randomised adult study with T-Booster and placebo groups.
66,000 capsules manufactured for study and scale-up learning.
Led by Dr Md Arif Sheikh with Dr David Brown as scientific advisor.
Thymus biology
Why the thymus mattersthroughout adult life
The thymus develops precursor cells into specialised T cells that support defence, immune memory and surveillance. Its natural decline with age makes thymus biology central to healthy immune ageing.
Anatomy and location
Located behind the breastbone, the thymus is where immune precursor cells mature into specialised T cells.
T-cell development
T cells learn to recognise biological threats while limiting inappropriate or misdirected immune reactions.
Immune defence
New T cells strengthen responses to infection and support immune surveillance of abnormal cells.
Natural age-related change
Thymic activity naturally declines with age, reducing the output and diversity of newly formed T cells.
Measuring thymic output
TREC DNA provides a biological measure of thymic output and can help track changes in thymic activity over time.
T-Booster development
Science-led developmentof an 18-ingredient blend
Development began with machine learning and computer modelling. Scientific review guided evidence and ingredient assessment, while AI strengthened analysis without replacing scientific judgement.
Structured research
A structured research programme established the scientific basis for the clinical evaluation that followed.
Multidisciplinary input
Scientific, clinical and formulation specialists guided each stage of the development programme.
AI-enhanced modelling
Machine learning and computer modelling were strengthened through AI-assisted analysis.
Formulation discipline
Every ingredient was reviewed for rationale, dose, safety and practical manufacturing suitability.
Formulation principles
Principles behind theT-Booster formulation
T-Booster combines carefully selected nutritional ingredients to support normal immune function. It complements, but does not replace, medical care, vaccination, a balanced diet or a healthy lifestyle.
Natural ingredient blend
A broad natural combination built around thymus and immune-health biology.
UK GMP production route
A 66,000-capsule batch supports manufacturing and the route to market.
Vegan-friendly positioning
No artificial colours, with vegan-friendly and allergen-aware positioning.
Human clinical study
Structured humanclinical evaluation
Participant involvement is complete and laboratory analysis continues. Statistical review, publication preparation and intellectual-property work now support an evidence-led route towards commercial launch.
Study statusParticipation complete
Current phaseFinal analysis
Study siteBSMMU, Dhaka
Duration12 months
- Randomisedstudy
- Double-blindstudy
- Placebo-controlled
- 260adults
TREC DNA
A DNA marker of newly produced T cells.
Blood analysis
CBC and immune-cell measures add biological context.
Participant experience
18 lifestyle questions captured changes across energy, sleep, stress, pain, urinary health, mood, skin and sexual wellbeing.
- Primary endpointTREC DNA measuredby qPCR
- Secondary endpointsCBC, safetyand wellbeing
Questionnaire outcomes
Questionnaire signalsin wellbeing outcomes
Questionnaires compared responses at the start and end of the programme. The clearest positive signals appeared in sleep, urinary health and energy, with final interpretation also considering blinded biological analysis.
Questionnaires were completed at baseline and programme end to compare changes in everyday wellbeing. Analysis focused on participants who reported each concern at baseline, allowing responses at the start and end of the programme to be considered on a like-for-like basis.
The strongest positive signals appeared in sleep, urinary health and energy, with additional changes in mood, sexual wellbeing, pain, skin and stress. These participant-reported outcomes provide context and will be interpreted alongside the blinded placebo comparison, TREC DNA, complete blood count and final statistical analysis.
How to read the chart
- Baseline-specific analysisOnly participants reporting each concern at baseline are included.
- Start-to-end comparisonResponses recorded at programme entry and completion are compared.
- Biological interpretationQuestionnaire signals complement, but do not replace, blinded laboratory outcomes.
T-Booster film
The science and visionbehind T-Booster
The film presents the thymus rationale, formulation and scientific programme behind T-Booster. It also introduces the wider vision for responsible consumer-health, healthy-ageing innovation and future scientific development.
Inside the programme
A science-led consumer-health platform
The film explores how thymus biology, ingredient selection, formulation development and drug-discovery experience came together to shape T-Booster, alongside the wider vision for healthy immune ageing and responsible consumer-health innovation.
Thymus biologyImmune ageing18 ingredientsFormulation rationaleScientific journeyProduct developmentResponsible innovationDrug-discovery leadership
Official presentation
Reversing Ageing
The power of thymus reactivation
▶Watch presentationOpen on YouTube ↗
Leadership
Drug-discovery leadersbehind T-Booster
Dr Md Arif Sheikh leads biology, formulation and drug discovery. Dr David Brown contributes five decades of pharmaceutical R&D experience. Together, they guide clinical and commercial development.
Dr Md Arif Sheikh is the scientific architect behind T-Booster. A molecular and structural biologist with more than 19 years of international drug-discovery experience, he has contributed to more than 45 protein structures and leads formulation, clinical evaluation and commercial development.
Dr David Brown is a pharmaceutical drug discoverer with more than 50 years of experience across major global companies. A co-inventor on the Viagra patent, he brings disciplined R&D, formulation and commercial perspective to T-Booster as scientific advisor.
Investors & strategic partners
Clinical work completedtowards commercial launch
We welcome strategic investors, distributors, consumer-health companies and scientific collaborators.
Frequently asked questions
Common questionsabout T-Booster
This section covers availability, study progress, intended use and responsible positioning. Further updates will follow as scientific analysis, publication work, intellectual-property activity and launch preparation continue.
Is T-Booster available to buy?
T-Booster is moving towards commercial launch. Contact the team for confirmed availability information.
Has the human study finished?
Participant involvement is complete. Laboratory analysis, statistical interpretation and publication are being finalised.
What is T-Booster intended to do?
It is positioned responsibly as a food supplement intended to support thymus function and healthy immune ageing.
Is this a medical treatment?
No. T-Booster is not intended to diagnose, treat, cure or prevent disease.